Myriad Genetics Up 6.4% Since Gabelli & Co Downgraded One Week Ago (MYGN)

Gabelli & Co downgraded Myriad Genetics (NASDAQ:MYGN) from Buy to Hold a week ago. Myriad Genetics stocks closed at $20.96, a 6.4% gain over the course of one week.There...